Alliancebernstein L.P. Paratek Pharmaceuticals, Inc. Transaction History

Alliancebernstein L.P.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.73 - $3.09 $110,374 - $197,142	-63,800 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.94 - $4.77 $588 - $953	200 Added 0.31%	63,800 $189,000
Q2 2021 Jul 30, 2021	BUY	$6.81 - $10.93 $66,738 - $107,114	9,800 Added 18.22%	63,600 $434,000
Q1 2021 May 06, 2021	SELL	$6.14 - $8.31 $27,016 - $36,564	-4,400 Reduced 7.56%	53,800 $380,000
Q4 2020 Feb 08, 2021	SELL	$4.58 - $7.14 $17,404 - $27,132	-3,800 Reduced 6.13%	58,200 $364,000
Q2 2020 Aug 13, 2020	BUY	$2.97 - $5.22 $16,632 - $29,232	5,600 Added 9.93%	62,000 $324,000
Q1 2020 May 14, 2020	BUY	$2.67 - $4.97 $26,967 - $50,197	10,100 Added 21.81%	56,400 $178,000
Q2 2019 Aug 14, 2019	BUY	$3.47 - $6.32 $7,287 - $13,272	2,100 Added 4.75%	46,300 $185,000
Q1 2019 May 14, 2019	SELL	$5.36 - $7.24 $10,720 - $14,480	-2,000 Reduced 4.33%	44,200 $237,000
Q4 2018 Feb 13, 2019	BUY	$4.8 - $11.6 $9,600 - $23,200	2,000 Added 4.52%	46,200 $237,000
Q2 2018 Aug 13, 2018	BUY	$10.2 - $13.9 $106,079 - $144,560	10,400 Added 30.77%	44,200 $451,000
Q1 2018 May 14, 2018	BUY	$12.65 - $18.85 $91,080 - $135,720	7,200 Added 27.07%	33,800 $439,000
Q3 2017 Nov 13, 2017	BUY	$18.9 - $28.2 $502,739 - $750,120	26,600	26,600 $668,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.